PriceTracker GLP-1
Loading the index…

Try

Find the cheapest for me
Loading the index…

Try

GLP-1 TV · Clinician

GLP-1s: Safe Dosing, Nutrition & Impact on Longevity | Rhonda Patrick, Ph.D.

Clinician8:04Oct 2025

Today’s cheapest GLP-1$39/mo at Wellmedr, sale price.Compare all GLP-1 prices Price read 22 Nov 2026 from the seller’s own page, ranked by price alone. That price is a compounded drug, and compounded drugs are not FDA-approved. Not from the video’s creator.

Our summary

In this clip from the channel video featuring Rhonda Patrick, Ph.D., the physician describes how his practice now approaches tirzepatide. He says about 15 to 20% of his patients are on it. Five years ago, when they started using semaglutide, he was watching patients lose muscle and had doubts about the drugs. Today he says virtually anyone can use them safely, including for long-term muscle health, but it takes a lot of deliberate attention. He says tirzepatide can make heavy foods like steak, chicken breast or omelettes unappealing, so patients aiming for 1.6 (the protein target he mentions) may rely on liquid shakes. He says DEXA scans before and after show less muscle loss than with their earlier approach.

Published by Peter Attia MD on YouTube

As published by the channel. Not medical advice, and not an endorsement.

What else the video covers

On dosing, he says tirzepatide starts at 2.5 mg and some people get enough benefit there. He favors slow and steady use and advises against yo-yoing on and off, which he calls probably a bad idea. He says the data suggest most of the benefit comes by about 10 mg, and that 5 to 7.5 mg is probably where the majority of the benefit is, with 12.5 and 15 mg adding some more.

He then discusses whether GLP-1 drugs are geroprotective independent of weight loss. He describes giving 2.5 mg per day to a few patients without obesity, including two with diabetes at low body weight, and says one person's glucose tolerance test nearly normalized within 3 months without weight loss. He also relays patient reports, which he says are unproven, that injecting in the abdomen gives a stronger appetite effect than the leg or butt.

Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.

Takeaways

The main points, in the order they come up. Tap a time to play from there.

  1. 0:00 The speaker says 15 to 20% of his patients are on tirzepatide and that he now thinks virtually anyone can use these drugs safely with deliberate attention to muscle.
  2. 0:31 He says easy-to-digest protein such as liquid shakes may be needed to hit the protein target on tirzepatide, and reports less muscle loss on DEXA than before.
  3. 1:31 He recommends slow and steady dosing, starting at 2.5 mg, and says yo-yoing on and off is probably a bad idea.
  4. 2:31 He says most of the benefit appears by about 10 mg, with 5 to 7.5 mg of tirzepatide likely giving the majority.
  5. 4:00 He describes using 2.5 mg daily in patients without obesity, with one patient's glucose tolerance test nearly normalizing in 3 months and no weight loss.
  6. 4:48 He relays anecdotal patient reports that abdominal injections have a stronger appetite-reducing effect than leg or butt injections, which he says needs study.

Key moments

Tap one to play from there.

  1. 0:00 Managing muscle on GLP-1s
  2. 1:33 Dosing and weight loss strategy
  3. 3:02 Health risks and considerations
  4. 4:21 Metabolic benefits without weight loss
  5. 7:05 Injection sites and future research

What the video says

As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.

Side effects mentioned
muscle loss

Questions this video answers

What tirzepatide dose gives most of the benefit?

According to the speaker, the data suggest most of the benefit comes by about 10 mg, and 5 to 7.5 mg is probably where the majority of it occurs. He says the 12.5 and 15 mg doses still add some benefit.

Is it bad to go on and off GLP-1 drugs?

The speaker says anecdotal data he has seen and heard suggest yo-yoing on and off these drugs is probably a bad idea. He says he would rather a patient stay at 2.5 mg than lose a lot of weight at a higher dose, stop, and regain.

How do you protect muscle while taking tirzepatide?

He says patients need to hit a protein target of 1.6 and may need easy-to-digest sources such as liquid shakes, since the drug can make heavy foods unappealing. He says DEXA scans before and after show less muscle loss than with their earlier approach.

Does injection site affect GLP-1 appetite suppression?

The speaker says some patients report stronger appetite effects when injecting in abdominal fat than in the leg or butt. He says he does not know if this is correct and that it would need to be studied.

Videos on the same question

The closest videos in the library by what is said in them, not by title.

Read next

Our guides closest to what this video covers, with prices checked weekly.

  • GLP-1 muscle loss: how much of the weight is muscle, and what protects it

    On semaglutide or tirzepatide, roughly a quarter to two fifths of the weight you lose is lean mass rather than fat: 25% in tirzepatide's SURMOUNT-1 scan substudy, and 25% to 39% across 20 randomised trials. That share is close to what diet-only weight loss costs. Lean mass is not all muscle, and strength held up in the shorter trials. Resistance training cut the lean share to 17.5% in the pooled trials, and expert groups pair it with enough protein.

  • Tirzepatide vs semaglutide: the head-to-head result, and what the better one costs

    They were finally tested against each other. In SURMOUNT-5, 751 adults with obesity took the maximum tolerated dose of one or the other for 72 weeks: tirzepatide lost 20.2% of body weight, semaglutide 13.7%. That gap is real and it is the whole argument for tirzepatide. The other half of the decision is the bill: compounded tirzepatide runs from $69 a month on our board against $39 for semaglutide, and the branded gap is wider still.

  • Mounjaro for weight loss, and why Zepbound exists

    Mounjaro is tirzepatide approved for type 2 diabetes. Zepbound is the same molecule from the same maker, approved for weight management, and it goes to the same 15 mg. So unlike Ozempic and Wegovy, there is no dose ceiling pushing you from one to the other: the reason people move is coverage and cash price, not strength. Using Mounjaro for weight is off-label and a prescriber's decision. In the one head-to-head trial, tirzepatide beat semaglutide, 20.2% mean body-weight loss at 72 weeks against 13.7%.

Next steps

Compounded semaglutide prices

Find more like it

Dose changeHow it worksMuscle loss

Up next

More from this collection

Watched it? See what it costs.

Every GLP-1 program we track, ranked by what actually leaves your account.

Back to GLP-1 TV